Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
7. Court overturns Fresenius’ $83M Medicare fraud loss
A federal appeals court says there was no evidence that Fresenius submitted false claims to Medicare, overturning a $82.6 million whistleblower suit brought by former employees.
6. Insurers look to recoup costs from faulty medical devices
As the number of recalled medical devices soars, insurers are increasingly looking to recoup the costs incurred by the recalls.
5. Accuray CEO Euan Thomson quits company, replaced by Joshua Levine
Euan Thomson abruptly resigns from Sunnyvale, Calif.-based medical device maker Accuray, will be replaced by former Mentor Corp., Immucor CEO.
4. Report: Implantable medical devices no longer a rising star
Implantable devices are a consistently high-performing segment in the medical device industry, but that advantage may be on the decline, according to a PricewaterhouseCoopers report.
3. Is Medical device tax a lame duck? Industry insiders look for repeal after election
Some medtech industry insiders are aiming optimistically for the "lame duck" period between election day and the seating of a new Congress to push efforts to repeal the 2.3% medical device tax – regardless of who wins the White House.
2. Heart valves: Edwards Lifesciences, Medtronic to face stiffer competition
Edwards Lifesciences and Medtronic may be on top of the heart valve market, but with about a dozen new device slated to hit the market in the coming years, their competition is about to get a lot stiffer.
1. Report: St. Jude probed Riata problems in 2005
St. Jude Medical first learned of potential problems with its Riata pacemaker lead in 2005, 6 years ahead of its recall of the medical devices.
